Document is current
Any future updates will be listed below
-
Authors
Morel, Chantal M.
Lindahl, Olof
Harbarth, Stephan
de Kraker, Marlieke E. A.
Edwards, Suzanne
Hollis, Aidan
-
Funding
Funding for this research was provided by:
Swiss National Fund
Vetenskapsrådet
Canadian Institute for Health Research
- License Information
-
More Information
Article History
Received: 17 February 2020
Accepted: 22 February 2020
First Online: 19 March 2020
Compliance with ethical standards
:
: As part of a separate project MK has received support from the Innovative Medicines Initiative Joint Undertaking (IMI) under grant agreement nos. 115523, 115620, and 115737 (Combatting Bacterial Resistance in Europe projects (COMBACTE)), resources of which are composed of financial contribution from the European Union’s 7th Framework Programme (FP7/2007 ± 2013) and the European Federation of Pharmaceutical Industries and associations (EFPIA) companies’ in-kind contribution. SH was member (2017–2018) of the scientific advisory board of Sandoz. The authors declare that they have no conflict of interest.
